Last reviewed · How we verify

NCT05036772: Daphné

Assessment of Patients' Pain and Anxiety During a Hysterosalpingography Narratified by a Virtual Reality Helmet (Daphné)

Completed NA Last updated 3 December 2024
What this trial tests

NA trial testing Virtual reality in Salpingography in 60 participants. Completed in 8 March 2024.

Timeline
30 May 2022
Primary endpoint
8 March 2024
8 March 2024

Quick facts

Lead sponsorPoitiers University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date30 May 2022
Primary completion8 March 2024
Estimated completion8 March 2024
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Poitiers University Hospital

Who can join

18 and older, female only, with Salpingography or Virtual Reality Exposure Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Compare the maximum pain and anxiety experienced between the group using a virtual reality headset and the control group in an adult woman during a hysterosalpingography examination

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Virtual reality

Trials testing the same drug.

Other Poitiers University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05036772.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing